DanDrit Biotech USA
2001
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
M&A
LATEST DEAL TYPE
3
FINANCING ROUNDS
Description
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing gene therapies. It develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Enochian Biopharma
Former Stock Listing
ENOB
Primary Office
- 375 Park Avenue
- Suite 2607
- New York, NY 10152
- United States
DanDrit Biotech USA Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore DanDrit Biotech USA‘s full profile, request access.
Request full access to PitchBook